Meridian Bioscience to Hold Second Quarter Fiscal 2021 Financial Results Conference Call on May 7, 2021

Rhea-AI Summary

Meridian Bioscience (NASDAQ: VIVO) will release its second quarter fiscal 2021 financial results on May 7, 2021. CEO Jack Kenny and CFO Bryan Baldasare will conduct a conference call at 10:00 a.m. ET to discuss the results. Investors can dial in using the numbers provided for participation, with a replay available for 14 days post-call. Meridian Bioscience focuses on innovative diagnostic products and life science raw materials for various applications, serving over 70 countries globally.

Positive

• Meridian is set to report financial results that may provide insights into growth metrics.
• The upcoming conference call presents investors with an opportunity to engage with company leadership.

Negative

• None.

CINCINNATI, April 19, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report second quarter fiscal 2021 financial results Friday, May 7, 2021.

Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and Chief Financial Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions.

To participate in the live call by telephone from the U.S., dial (866) 443-5802, or from outside the U.S., dial (513) 360-6924, and enter the audience pass code 9948805.

A replay will be available for 14 days beginning at 1:00 p.m. Eastern Time on May 7, 2021 by dialing (855) 859-2056 or (404) 537-3406 and entering pass code 9948805.

About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com. 

Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com

FAQ

When will Meridian Bioscience report its Q2 2021 earnings?

Meridian Bioscience will report its second quarter fiscal 2021 financial results on May 7, 2021.

What time is the conference call for Meridian Bioscience's financial results?

The conference call will start at 10:00 a.m. Eastern Time on May 7, 2021.

How can I participate in Meridian Bioscience's earnings call?

To participate, call (866) 443-5802 from the U.S. or (513) 360-6924 from outside the U.S. and use the pass code 9948805.

Is there a replay available for Meridian Bioscience's earnings call?

Yes, a replay will be available for 14 days after the call starting at 1:00 p.m. ET on May 7, 2021.

What does Meridian Bioscience do?

Meridian Bioscience develops, manufactures, and distributes diagnostic products and life science raw materials.